The composition of the weight-reduction plan impacts many processes within the physique, together with physique weight and endocrine system. Now we have beforehand proven that dietary fats additionally impacts the immune system. Mice fed excessive fats weight-reduction plan wealthy in polyunsaturated fatty acids survive S. aureus an infection to a a lot higher extent than mice fed excessive fats weight-reduction plan wealthy in saturated fatty acids. Right here we current information concerning the dietary results on protein expression in spleen from mice fed three totally different diets, I) low fats/chow weight-reduction plan (LFD, n = 4), II) excessive fats weight-reduction plan wealthy in saturated fatty acids (HFD-S, n = 4) and III) excessive fats weight-reduction plan wealthy in polyunsaturated fatty acids (HFD-P, n = 4).
We carried out mass spectrophotometry based mostly quantitative proteomics evaluation of remoted spleen by implementing the isobaric tags for relative and absolute quantification (iTRAQ) method. Mass spectrometry information had been analyzed utilizing Proteome Discoverer 2.Four software program utilizing the search engine mascot towards Mus musculus in SwissProt. 924 proteins are recognized in all units (n = 4) for various dietary results taken for statistical evaluation utilizing Qlucore Omics Explorer software program. Solely 20 proteins had been discovered to be differentially expressed with a cut-off worth of false discovery price < 0.1 (q-value) when evaluating HFD-S and HFD-P however no differentially expressed proteins had been discovered when LFD was in contrast with HFD-P or HFD-S. The recognized proteins and statistical evaluation evaluating HFD-S and HFD-P diets can be found as a supplementary file S1. We recognized a subset of proteins that confirmed an inverse expression sample between two excessive fats diets. These differentially expressed proteins had been additional categorised by gene ontology for his or her position in organic processes and molecular features. Mass spectrometry uncooked information are additionally out there by way of ProteomeXchange with identifier PXD020365.
Prime-down mass spectrometry (MS)-based proteomics permits a complete evaluation of proteoforms with molecular specificity to attain a proteome-wide understanding of protein features. Nonetheless, the shortage of a common software program for top-down proteomics is changing into more and more acknowledged as a significant barrier particularly for newcomers. Right here we develop MASH Explorer, a common, complete, and user-friendly software program surroundings for top-down proteomics. MASH Explorer integrates a number of spectral deconvolution and database looking out algorithms right into a single, common platform which might course of top-down proteomics information from varied vendor codecs, for the primary time. It addresses the pressing want within the quickly rising top-down proteomics neighborhood and is freely out there to all customers worldwide. With the vital want and large help from the neighborhood, we envision this MASH Explorer software program package deal will play an integral position in advancing top-down proteomics to understand its full potential for biomedical analysis.
Theoretical minimal RNA rings mimick molecular evolution earlier than tRNA-mediated translation: codon-amino acid affinities improve from early to late RNA rings
Nucleotide affinities for noncovalent interactions with amino acids produce associations between mRNAs and cognate peptides, doubtlessly regulating ribosomal translation. Correlations between nucleotide affinities and residue hydrophobicity are explored for 25 theoretical minimal RNA rings, 22 nucleotide-long RNAs designed in silico to code for every amino acid as soon as after three translation rounds, and forming stem-loop hairpins. This design presumably mimicks life’s first RNAs. RNA rings resemble consensual tRNAs, suggesting proto-tRNA operate, predicted anticodon and cognate amino acid. The 25 RNA rings and their presumed evolutionary order, deduced from the genetic code integration order of the amino acid cognate to their predicted anticodon, produces noteworthy associations with a number of historical properties of the cell’s translational equipment. Right here we use this method to discover the evolution of codon affinity-residue hydrophobicity correlations, assuming these replicate pre-tRNA and pre-ribosomal translations.
This speculation expects that correlations lower with genetic code inclusion orders of RNA ring cognates. RNA ring associations between nucleotide affinities and residue hydrophobicities resemble these from fashionable pure genes/proteins. Affiliation strengths lower with genetic code inclusion ranks of proto-tRNA cognate amino acids. In silico design of minimal RNA rings did not account for affinities between RNA and peptides coded by these RNAs. But, interactions between RNA rings and translated cognate peptides resemble fashionable pure genes.
This property is strongest for historical RNA rings, weakest for current RNA rings, spanning a interval throughout which fashionable tRNA- and ribosome-based translation presumably advanced. Outcomes point out that translation missing tRNA-like adaptors based mostly on codon-amino acid affinities and the genetic code pre-existed tRNA-mediated translation. Theoretical minimal RNA rings seem legitimate prebiotic peptide-RNA world fashions for the transition between pre-tRNA- and tRNA-mediated translations.
[Correlation between hyponatremia and the severity of coronavirus disease 2019]
Among the many 12 sufferers with COVID-19, there have been eight males and Four females with the imply age of (38.0±16.3) years previous, most of them had been admitted to the hospital with cough and/or fever. All sufferers had a constructive nucleic acid take a look at for 2019 novel coronavirus (2019-nCoV), and had been discharged after medical therapy with oxygen remedy, antiviral, antibacterial, anti-inflammatory, and dietary help. All sufferers had been of peculiar kind once they had been admitted to the hospital.
 Protein) Granulysin (GNLY) Protein |
|
20-abx262124 |
Abbexa |
-
EUR 393.60
-
EUR 6106.80
-
EUR 276.00
|
|
|
|
 GNLY Granulysin Human Recombinant Protein |
|
PROTP22749 |
BosterBio |
Regular: 10ug |
EUR 380.4 |
|
Description: GNLY Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 159 amino acids and fused to a double His Tag (N+C terminus) and having a total molecular mass of 18.1 kDa.;The GNLY is purified by proprietary chromatographic techniques. |
 GNLY siRNA |
|
20-abx918218 |
Abbexa |
|
|
|
|
 GNLY Antibody |
|
43674-100ul |
SAB |
100ul |
EUR 302.4 |
 anti-GNLY |
|
YF-PA17076 |
Abfrontier |
50 ug |
EUR 435.6 |
|
Description: Mouse polyclonal to GNLY |
 Human GNLY shRNA Plasmid |
|
20-abx957198 |
Abbexa |
|
|
|
|
 GNLY Conjugated Antibody |
|
C43674 |
SAB |
100ul |
EUR 476.4 |
 GNLY cloning plasmid |
|
CSB-CL009627HU-10ug |
Cusabio |
10ug |
EUR 279.6 |
|
|
|
Description: A cloning plasmid for the GNLY gene. |
 GNLY Polyclonal Antibody |
|
ES11035-100ul |
ELK Biotech |
100ul |
EUR 334.8 |
|
Description: A Rabbit Polyclonal antibody against GNLY from Human. This antibody is tested and validated for WB, ELISA, WB, ELISA |
GNLY Polyclonal Antibody |
|
ES11035-50ul |
ELK Biotech |
50ul |
EUR 248.4 |
|
Description: A Rabbit Polyclonal antibody against GNLY from Human. This antibody is tested and validated for WB, ELISA, WB, ELISA |
 Antibody) Granulysin (GNLY) Antibody |
|
20-abx172666 |
Abbexa |
|
|
|
|
GNLY Polyclonal Antibody |
|
ABP58659-003ml |
Abbkine |
0.03ml |
EUR 189.6 |
|
|
|
Description: A polyclonal antibody for detection of GNLY from Human. This GNLY antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human GNLY protein |
GNLY Polyclonal Antibody |
|
ABP58659-01ml |
Abbkine |
0.1ml |
EUR 346.8 |
|
|
|
Description: A polyclonal antibody for detection of GNLY from Human. This GNLY antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human GNLY protein |
GNLY Polyclonal Antibody |
|
ABP58659-02ml |
Abbkine |
0.2ml |
EUR 496.8 |
|
|
|
Description: A polyclonal antibody for detection of GNLY from Human. This GNLY antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human GNLY protein |
Granulysin (GNLY) Antibody |
|
abx027191-400ul |
Abbexa |
400 ul |
EUR 627.6 |
|
|
Granulysin (GNLY) Antibody |
|
abx027191-80l |
Abbexa |
80 µl |
EUR 343.2 |
|
|
Granulysin (GNLY) Antibody |
|
20-abx176697 |
Abbexa |
|
|
|
|
 Anti-GNLY antibody |
|
STJ192193 |
St John's Laboratory |
200 µl |
EUR 236.4 |
|
Description: Unconjugated Rabbit polyclonal to GNLY |
) Anti-GNLY (2A6) |
|
YF-MA17387 |
Abfrontier |
100 ug |
EUR 435.6 |
|
Description: Mouse monoclonal to GNLY |
 Human granulysin, GNLY ELISA Kit |
|
CSB-E09936h-24T |
Cusabio |
1 plate of 24 wells |
EUR 198 |
|
|
|
Description: Quantitativesandwich ELISA kit for measuring Human granulysin, GNLY in samples from serum, plasma, cell culture supernates, tissue homogenates, urine. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
Human granulysin, GNLY ELISA Kit |
|
1-CSB-E09936h |
Cusabio |
-
EUR 1080.00
-
EUR 6571.20
-
EUR 3480.00
|
- 1 plate of 96 wells
- 10 plates of 96 wells each
- 5 plates of 96 wells each
|
|
|
|
Description: Quantitativesandwich ELISA kit for measuring Human granulysin, GNLY in samples from serum, plasma, cell culture supernates, tissue homogenates, urine. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
 Human GNLY/ Granulysin ELISA Kit |
|
E1028Hu |
Sunlong |
1 Kit |
EUR 685.2 |
ELISA Kit) Human granulysin(GNLY)ELISA Kit |
|
GA-E0371HM-48T |
GenAsia Biotech |
48T |
EUR 346.8 |
Human granulysin(GNLY)ELISA Kit |
|
GA-E0371HM-96T |
GenAsia Biotech |
96T |
EUR 559.2 |
 Human granulysin,GNLY ELISA Kit |
|
201-12-0355 |
SunredBio |
96 tests |
EUR 528 |
|
|
|
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
 ELISA Kit) Human Granulysin (GNLY) ELISA Kit |
|
20-abx151728 |
Abbexa |
-
EUR 8534.40
-
EUR 4550.40
-
EUR 1054.80
|
- 10 × 96 tests
- 5 × 96 tests
- 96 tests
|
|
|
 CLIA Kit) Human Granulysin (GNLY) CLIA Kit |
|
abx197066-96tests |
Abbexa |
96 tests |
EUR 990 |
|
|
Human Granulysin (GNLY) ELISA Kit |
|
abx571955-96tests |
Abbexa |
96 tests |
EUR 848.4 |
|
|
Human Granulysin (GNLY) CLIA Kit |
|
20-abx492830 |
Abbexa |
-
EUR 9567.60
-
EUR 5095.20
-
EUR 1177.20
|
- 10 × 96 tests
- 5 × 96 tests
- 96 tests
|
|
|
Human Granulysin (GNLY) ELISA Kit |
|
abx250848-96tests |
Abbexa |
96 tests |
EUR 848.4 |
|
|
 (OKBB01536)) GNLY ELISA Kit (Human) (OKBB01536) |
|
OKBB01536 |
Aviva Systems Biology |
96 Wells |
EUR 684 |
|
Description: Description of target: Granulysin is a substance released by cytotoxic T cells(CD8) when they are attached to infected body cells. The product of this gene is a member of the saposin-like protein(SAPLIP) family. It is mapped to 2p11.2. Granulysin functions to create holes in the target cell membrane and destroy it. It is able to induce apoptosis in target cells and also has antimicrobial action. This gene is expressed in cytolytic granules with perforin, a pore forming protein, and granzymes that are also involved in cytolysis. In addition to it, Granulysin is broadly antimicrobial, killing microbes that cause, for example, tuberculosis and malaria, and can destroy some tumors. A series of peptides generated from the amino acid sequence of Granulysin are potential antibiotics. It has been found that secretory Granulysin is a key molecule responsible for the disseminated keratinocyte death in SJS/TEN.;Species reactivity: Human;Application: ELISA;Assay info: ;Sensitivity: <10pg/ml |
 (OKAN05019)) GNLY ELISA Kit (Human) (OKAN05019) |
|
OKAN05019 |
Aviva Systems Biology |
96 Wells |
EUR 950.4 |
|
Description: Description of target: The product of this gene is a member of the saposin-like protein (SAPLIP) family and is located in the cytotoxic granules of T cells, which are released upon antigen stimulation. This protein is present in cytotoxic granules of cytotoxic T lymphocytes and natural killer cells, and it has antimicrobial activity against M. tuberculosis and other organisms. Alternatively spliced transcript variants encoding different isoforms have been identified.;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.08 ng/mL |
 (OKCD07459)) GNLY ELISA Kit (Human) (OKCD07459) |
|
OKCD07459 |
Aviva Systems Biology |
96 Wells |
EUR 1123.2 |
|
Description: Description of target: The product of this gene is a member of the saposin-like protein (SAPLIP) family and is located in the cytotoxic granules of T cells, which are released upon antigen stimulation. This protein is present in cytotoxic granules of cytotoxic T lymphocytes and natural killer cells, and it has antimicrobial activity against M. tuberculosis and other organisms. Alternatively spliced transcript variants encoding different isoforms have been identified.;Species reactivity: Human;Application: ELISA;Assay info: ;Sensitivity: < 0.08ng/mL |
 (pORF)) GNLY ORF Vector (Human) (pORF) |
|
ORF004527 |
ABM |
1.0 ug DNA |
EUR 114 |
 ELISA Kit) Human GNLY(Granulysin) ELISA Kit |
|
EH0156 |
FN Test |
96T |
EUR 628.92 |
|
|
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 0.141 ng/ml |
Human Granulysin (GNLY) ELISA Kit |
|
SEB517Hu-10x96wellstestplate |
Cloud-Clone |
10x96-wells test plate |
EUR 5402.92 |
|
|
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Granulysin (GNLY) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
Human Granulysin (GNLY) ELISA Kit |
|
SEB517Hu-1x48wellstestplate |
Cloud-Clone |
1x48-wells test plate |
EUR 550.13 |
|
|
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Granulysin (GNLY) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
Human Granulysin (GNLY) ELISA Kit |
|
SEB517Hu-1x96wellstestplate |
Cloud-Clone |
1x96-wells test plate |
EUR 734.46 |
|
|
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Granulysin (GNLY) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
Human Granulysin (GNLY) ELISA Kit |
|
SEB517Hu-5x96wellstestplate |
Cloud-Clone |
5x96-wells test plate |
EUR 2945.08 |
|
|
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Granulysin (GNLY) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
Human Granulysin (GNLY) ELISA Kit |
|
4-SEB517Hu |
Cloud-Clone |
-
EUR 5463.60
-
EUR 2886.00
-
EUR 735.60
|
- 10 plates of 96 wells
- 5 plates of 96 wells
- 1 plate of 96 wells
|
|
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Granulysin (GNLY) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids with no significant corss-reactivity with analogues from other species. |
) Human Granulysin ELISA Kit (GNLY) |
|
RK01482 |
Abclonal |
96 Tests |
EUR 625.2 |
 (pPB-C-His)) GNLY Protein Vector (Human) (pPB-C-His) |
|
PV018105 |
ABM |
500 ng |
EUR 394.8 |
 (pPB-N-His)) GNLY Protein Vector (Human) (pPB-N-His) |
|
PV018106 |
ABM |
500 ng |
EUR 394.8 |
 (pPM-C-HA)) GNLY Protein Vector (Human) (pPM-C-HA) |
|
PV018107 |
ABM |
500 ng |
EUR 394.8 |
 (pPM-C-His)) GNLY Protein Vector (Human) (pPM-C-His) |
|
PV018108 |
ABM |
500 ng |
EUR 394.8 |
 Recombinant Human GNLY Protein, His, E.coli-10ug |
|
QP12021-10ug |
EnQuireBio |
10ug |
EUR 241.2 |
 Recombinant Human GNLY Protein, His, E.coli-1mg |
|
QP12021-1mg |
EnQuireBio |
1mg |
EUR 4983.6 |
 Recombinant Human GNLY Protein, His, E.coli-2ug |
|
QP12021-2ug |
EnQuireBio |
2ug |
EUR 186 |
) ELISA kit for Human GNLY (Granulysin) |
|
E-EL-H1618 |
Elabscience Biotech |
1 plate of 96 wells |
EUR 640.8 |
|
|
|
Description: A sandwich ELISA kit for quantitative measurement of Human GNLY (Granulysin) in samples from Serum, Plasma, Cell supernatant |
) CLIA kit for Human GNLY (Granulysin) |
|
E-CL-H1038 |
Elabscience Biotech |
1 plate of 96 wells |
EUR 700.8 |
|
|
|
Description: A sandwich CLIA kit for quantitative measurement of Human GNLY (Granulysin) in samples from Serum, Plasma, Cell supernatant |
ELISA kit for Human GNLY (Granulysin) |
|
ELK2059 |
ELK Biotech |
1 plate of 96 wells |
EUR 518.4 |
|
|
|
Description: A sandwich ELISA kit for detection of Granulysin from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
) GNLY sgRNA CRISPR Lentivector set (Human) |
|
K0878801 |
ABM |
3 x 1.0 ug |
EUR 406.8 |
 ELISA Kit) Chicken Granulysin (GNLY) ELISA Kit |
|
abx354664-96tests |
Abbexa |
96 tests |
EUR 990 |
|
|
 ELISA Kit) Monkey Granulysin (GNLY) ELISA Kit |
|
abx354943-96tests |
Abbexa |
96 tests |
EUR 990 |
|
|
 ELISA Kit) Pig Granulysin (GNLY) ELISA Kit |
|
abx355092-96tests |
Abbexa |
96 tests |
EUR 990 |
|
|
 ELISA Kit) Rabbit Granulysin (GNLY) ELISA Kit |
|
abx355341-96tests |
Abbexa |
96 tests |
EUR 990 |
|
|
 : 96 Wells (OKEH02758)) GNLY ELISA Kit (Human) : 96 Wells (OKEH02758) |
|
OKEH02758 |
Aviva Systems Biology |
96 Wells |
EUR 794.4 |
|
Description: Description of target: The product of this gene is a member of the saposin-like protein (SAPLIP) family and is located in the cytotoxic granules of T cells, which are released upon antigen stimulation. This protein is present in cytotoxic granules of cytotoxic T lymphocytes and natural killer cells, and it has antimicrobial activity against M. tuberculosis and other organisms. Alternatively spliced transcript variants encoding different isoforms have been identified.;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.156 ng/mL |
 (Target 1)) GNLY sgRNA CRISPR Lentivector (Human) (Target 1) |
|
K0878802 |
ABM |
1.0 ug DNA |
EUR 184.8 |
 (Target 2)) GNLY sgRNA CRISPR Lentivector (Human) (Target 2) |
|
K0878803 |
ABM |
1.0 ug DNA |
EUR 184.8 |
 (Target 3)) GNLY sgRNA CRISPR Lentivector (Human) (Target 3) |
|
K0878804 |
ABM |
1.0 ug DNA |
EUR 184.8 |
 GNLY 3'UTR GFP Stable Cell Line |
|
TU059013 |
ABM |
1.0 ml |
EUR 1672.8 |
 GNLY 3'UTR Luciferase Stable Cell Line |
|
TU009013 |
ABM |
1.0 ml |
EUR 1672.8 |
) GNLY sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
|
K0878805 |
ABM |
3 x 1.0 ug |
EUR 451.2 |
 (Target 1)) GNLY sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1) |
|
K0878806 |
ABM |
1.0 ug DNA |
EUR 200.4 |
 (Target 2)) GNLY sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2) |
|
K0878807 |
ABM |
1.0 ug DNA |
EUR 200.4 |
 (Target 3)) GNLY sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
|
K0878808 |
ABM |
1.0 ug DNA |
EUR 200.4 |
 Protein) Human Prion Protein (PRNP) Protein |
|
20-abx068667 |
Abbexa |
-
EUR 828.00
-
EUR 343.20
-
EUR 2532.00
-
EUR 978.00
-
EUR 594.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
 Protein) Human Protein C (PROC) Protein |
|
20-abx068731 |
Abbexa |
-
EUR 910.80
-
EUR 360.00
-
EUR 2865.60
-
EUR 1095.60
-
EUR 644.40
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
 Protein) Human Protein S (PROS) Protein |
|
20-abx068765 |
Abbexa |
-
EUR 594.00
-
EUR 292.80
-
EUR 1696.80
-
EUR 693.60
-
EUR 427.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
Human Protein S (PROS) Protein |
|
20-abx068766 |
Abbexa |
-
EUR 594.00
-
EUR 292.80
-
EUR 1696.80
-
EUR 693.60
-
EUR 427.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
 Protein) Human Kell Protein (KEL) Protein |
|
20-abx168735 |
Abbexa |
-
EUR 794.40
-
EUR 326.40
-
EUR 2448.00
-
EUR 944.40
-
EUR 577.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
 Protein) Human Translocator Protein (TSPO) Protein |
|
20-abx165906 |
Abbexa |
-
EUR 811.20
-
EUR 326.40
-
EUR 2481.60
-
EUR 961.20
-
EUR 577.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
 Protein) Human Protein Z (PROZ) Protein |
|
20-abx654876 |
Abbexa |
-
EUR 744.00
-
EUR 326.40
-
EUR 2230.80
-
EUR 878.40
-
EUR 543.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
Human Protein S (PROS) Protein |
|
abx670077-50ug |
Abbexa |
50 ug |
EUR 360 |
|
|
 BAD Protein Human Recombinant Protein |
|
PROTQ92934 |
BosterBio |
Regular: 5ug |
EUR 574.8 |
|
Description: Bcl2 antagonist of cell death (BAD) Human Recombinant full length protein expressed in E.coli, shows a 51 kDa band on SDS-PAGE(Icluding GST tag). ;The BAD protein is purified by proprietary chromatographic techniques. |
 PHF11 Protein Human Recombinant Protein |
|
PROTQ9UIL8 |
BosterBio |
Regular: 20ug |
EUR 380.4 |
|
Description: PHF11 Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 351 amino acids (1-331 a.a.) and having a molecular mass of 39.7kDa.;PHF11 is fused to a 20 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques. |
 p53 Protein Human Recombinant Protein |
|
PROTP04637-1 |
BosterBio |
Regular: 5ug |
EUR 574.8 |
|
Description: p53 Human Recombinant full length produced in E.Coli is a non-glycosylated, polypeptide chain having a total Mw of 81kDa. p53 Human Recombinant is fused to GST tag and purified by proprietary chromatographic techniques. |
 Human IgA protein |
|
31C-CH0922 |
Fitzgerald |
1 mg |
EUR 452.4 |
|
Description: Purified Human IgA protein |
Human IgA protein |
|
31R-1011 |
Fitzgerald |
1 mg |
EUR 205.2 |
|
Description: Purified Human IgA protein |
 Human IgM protein |
|
31R-1015 |
Fitzgerald |
1 mg |
EUR 212.4 |
|
Description: Purified Human IgM protein |
Human IgA protein |
|
31R-1035 |
Fitzgerald |
1 mg |
EUR 212.4 |
|
Description: Purified Human IgA protein for use as a control or blocking reagent |
 Human IgG protein |
|
31R-1057 |
Fitzgerald |
10 mg |
EUR 308.4 |
|
Description: Purified native IgG protein |
 Human IgG3 protein |
|
31R-1058 |
Fitzgerald |
10 mg |
EUR 2278.8 |
|
Description: Purified native IgG3 protein |
Human IgG3 protein |
|
31R-1058L |
Fitzgerald |
10 mg |
EUR 2278.8 |
|
Description: Native Human IgG3 protein |
Human IgA protein |
|
31R-AI001 |
Fitzgerald |
10 mg |
EUR 672 |
|
Description: Purified Human IgA protein |
Human IgG protein |
|
31R-AI034 |
Fitzgerald |
10 mg |
EUR 159.6 |
|
Description: Purified Human IgG protein |
Human IgM protein |
|
31R-AI037 |
Fitzgerald |
10 mg |
EUR 3062.4 |
|
Description: Purified Human IgM protein |
 Human Albumin protein |
|
30C-CH0925 |
Fitzgerald |
25 mg |
EUR 220.8 |
|
Description: Highly purified Human Albumin protein |
 Human IgA1 protein |
|
30C-CP7034 |
Fitzgerald |
1 mg |
EUR 255.6 |
|
Description: Purified Human IgA1 protein |
 Human IgA2 protein |
|
30C-CP8034 |
Fitzgerald |
1 mg |
EUR 296.4 |
|
Description: Purified Human IgA2 protein |
Human Albumin protein |
|
30R-AA008 |
Fitzgerald |
10 mg |
EUR 1180.8 |
|
Description: Highly purified Human Albumin protein, immunogen grade (>99% pure) |
Human Albumin protein |
|
30R-AH076 |
Fitzgerald |
10 mg |
EUR 289.2 |
|
Description: Highly purified Human Albumin protein |
 Human IgG4 protein |
|
31-1009 |
Fitzgerald |
100 ug |
EUR 346.8 |
|
Description: Purified Normal Human plasma IgG4 protein |
Human IgA protein |
|
31-AH05 |
Fitzgerald |
5 mg |
EUR 438 |
|
Description: Purified Human IgA protein |
Human IgM protein |
|
31-AH30 |
Fitzgerald |
5 mg |
EUR 564 |
|
Description: Purified Human IgM protein |
 Human IgE protein |
|
31-AI01 |
Fitzgerald |
100 ug |
EUR 606 |
|
Description: Purified Human IgE protein |
Human IgG protein |
|
31-AI06 |
Fitzgerald |
10 mg |
EUR 187.2 |
|
Description: Purified Human IgG protein |
 Human IgG1 protein |
|
31-AI17 |
Fitzgerald |
1 mg |
EUR 163.2 |
|
Description: Purified Human IgG1 protein |
 Human IgG2 protein |
|
31-AI18 |
Fitzgerald |
5 mg |
EUR 440.4 |
|
Description: Purified Human IgG2 protein |
Human IgG3 protein |
|
31-AI19 |
Fitzgerald |
1 mg |
EUR 489.6 |
|
Description: Purified native Human IgG3 protein |
Human IgM protein |
|
31-AI35 |
Fitzgerald |
10 mg |
EUR 438 |
|
Description: Purified Human IgM protein |
 Human AVP Protein |
|
30-1960 |
Fitzgerald |
50 ug |
EUR 310.8 |
|
Description: Recombinant Human Vasopressin-neurophysin 2-copeptin(AVP) |
) Rad51 Protein (Human) |
|
10-001 |
Sceti |
20ug |
EUR 574.8 |
|
Description: The Rad51 Protein (Human) is available in Europe and for worldwide shipping via Gentaur. |
) Rad52 Protein (Human) |
|
10-003 |
Sceti |
20ug |
EUR 574.8 |
|
Description: The Rad52 Protein (Human) is available in Europe and for worldwide shipping via Gentaur. |
Rad52 Protein (Human) |
|
10-004 |
Sceti |
100ug |
EUR 1420.8 |
|
Description: The Rad52 Protein (Human) is available in Europe and for worldwide shipping via Gentaur. |
 Human Ghrelin Protein |
|
20-abx066770 |
Abbexa |
-
EUR 543.60
-
EUR 276.00
-
EUR 1479.60
-
EUR 627.60
-
EUR 393.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
 Human PLAC9 Protein |
|
20-abx068557 |
Abbexa |
-
EUR 710.40
-
EUR 309.60
-
EUR 2131.20
-
EUR 844.80
-
EUR 526.80
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
 Human PHLDA2 Protein |
|
20-abx068605 |
Abbexa |
-
EUR 828.00
-
EUR 343.20
-
EUR 2548.80
-
EUR 978.00
-
EUR 594.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
 Human GLUT4 Protein |
|
20-abx168617 |
Abbexa |
-
EUR 693.60
-
EUR 309.60
-
EUR 2064.00
-
EUR 828.00
-
EUR 510.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
 Human DIABLO Protein |
|
abx060001-100ug |
Abbexa |
100 ug |
EUR 393.6 |
|
|
 Human C14orf166 Protein |
|
abx060002-100ug |
Abbexa |
100 ug |
EUR 393.6 |
|
|
 Human S100PBP Protein |
|
abx060003-100ug |
Abbexa |
100 ug |
EUR 393.6 |
|
|
 Human SAA4 Protein |
|
abx060004-100ug |
Abbexa |
100 ug |
EUR 393.6 |
|
|
 Human SUMO2 Protein |
|
abx060006-100ug |
Abbexa |
100 ug |
EUR 393.6 |
|
|
 Human ATOX1 Protein |
|
abx060007-100ug |
Abbexa |
100 ug |
EUR 393.6 |
|
|
 Human PARK7 Protein |
|
abx060008-100ug |
Abbexa |
100 ug |
EUR 393.6 |
|
|
 Human PRDX1 Protein |
|
abx060010-100ug |
Abbexa |
100 ug |
EUR 393.6 |
|
|
 Human CBX3 Protein |
|
abx060011-100ug |
Abbexa |
100 ug |
EUR 393.6 |
|
|
 Human HSD17B10 Protein |
|
abx060012-100ug |
Abbexa |
100 ug |
EUR 393.6 |
|
|
 Human PCMT1 Protein |
|
abx060015-100ug |
Abbexa |
100 ug |
EUR 393.6 |
|
|
 Human ANP32A Protein |
|
abx060016-100ug |
Abbexa |
100 ug |
EUR 393.6 |
|
|
 Human ALDOA Protein |
|
abx060017-100ug |
Abbexa |
100 ug |
EUR 393.6 |
|
|
 Human UBE2E3 Protein |
|
abx060018-100ug |
Abbexa |
100 ug |
EUR 393.6 |
|
|
 Human MLP3B Protein |
|
abx060019-100ug |
Abbexa |
100 ug |
EUR 393.6 |
|
|
 Human PTGDS2 Protein |
|
abx060021-100ug |
Abbexa |
100 ug |
EUR 393.6 |
|
|
 Human CKS1B Protein |
|
abx060022-100ug |
Abbexa |
100 ug |
EUR 393.6 |
|
|
 Human AKAP7 Protein |
|
20-abx060023 |
Abbexa |
|
|
|
|
 Human AK1 Protein |
|
20-abx060024 |
Abbexa |
|
|
|
|
 Human SP17 Protein |
|
abx060025-100ug |
Abbexa |
100 ug |
EUR 393.6 |
|
|
 Human CFL1 Protein |
|
abx060026-100ug |
Abbexa |
100 ug |
EUR 393.6 |
|
|
 Human CLIC2 Protein |
|
abx060027-100ug |
Abbexa |
100 ug |
EUR 393.6 |
|
|
 Human ANXA3 Protein |
|
abx060028-100ug |
Abbexa |
100 ug |
EUR 393.6 |
|
|
 Human RAP2B Protein |
|
abx060029-100ug |
Abbexa |
100 ug |
EUR 393.6 |
|
|
 Human ISG20 Protein |
|
abx060032-100ug |
Abbexa |
100 ug |
EUR 393.6 |
|
|
 Human SNRPF Protein |
|
abx060033-100ug |
Abbexa |
100 ug |
EUR 393.6 |
|
|
 Human KAAG1 Protein |
|
abx060034-100ug |
Abbexa |
100 ug |
EUR 393.6 |
|
|
 Human HMG14 Protein |
|
abx060035-100ug |
Abbexa |
100 ug |
EUR 393.6 |
|
|
Amongst them, 1 affected person changed into a extreme case throughout the course of the illness, and 1 affected person confirmed an inclination to change into extreme case. It was discovered that 10 sufferers with out extreme conversion had a median blood Na+ of (138.3±1.3) mmol/L at admission, and the bottom blood Na+ throughout the course of illness was (135.9±3.1) mmol/L. Nonetheless, 2 sufferers who turned extreme and had an inclination to change into extreme illness (Na+ ranges at admission had been 140.Zero mmol/L and 138.Zero mmol/L, respectively) skilled hyponatremia throughout the course of the illness (the bottom blood Na+ ranges had been 129.Zero mmol/L and 122.Zero mmol/L).
